CD8A and cancer: MHC-I molecules function to bind the encoded peptides, transport and display the antigenic information on the cell surface, and allow CD8+ T cells to identify pathological cells, such as cancers that are expressing mutated proteins (Dhatchinamoorthy et al., 2021).